Literature DB >> 15985542

Hemolysis-associated priapism in sickle cell disease.

Vikki G Nolan1, Diego F Wyszynski, Lindsay A Farrer, Martin H Steinberg.   

Abstract

Priapism, although uncommon in the general population, is one of the many serious complications associated with sickle cell disease (SCD). Few studies have described the clinical and hematologic characteristics of individuals with priapism and SCD. Using data from the Cooperative Study for Sickle Cell Disease, we assembled 273 case subjects with priapism and 979 control subjects. Case subjects, compared with control subjects, had significantly lower levels of hemoglobin; higher levels of lactate dehydrogenase, bilirubin, and aspartate aminotransferase; and higher reticulocyte, white blood cell, and platelet counts. These findings suggest an association of priapism with increased hemolysis. Hemolysis decreases the availability of circulating nitric oxide, which plays an important role in erectile function.

Entities:  

Mesh:

Year:  2005        PMID: 15985542      PMCID: PMC1283070          DOI: 10.1182/blood-2005-04-1594

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  54 in total

1.  Preventive treatment of priapism in sickle cell disease with oral and self-administered intracavernous injection of etilefrine.

Authors:  R Virag; D Bachir; K Lee; F Galacteros
Journal:  Urology       Date:  1996-05       Impact factor: 2.649

2.  Hydroxyurea reacts with heme proteins to generate nitric oxide.

Authors:  R Pacelli; J Taira; J A Cook; D A Wink; M C Krishna
Journal:  Lancet       Date:  1996-03-30       Impact factor: 79.321

Review 3.  Perspectives series: cell adhesion in vascular biology. Adhesive interactions of sickle erythrocytes with endothelium.

Authors:  R P Hebbel
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

Review 4.  Role of nitric oxide in the physiology of erection.

Authors:  A L Burnett
Journal:  Biol Reprod       Date:  1995-03       Impact factor: 4.285

5.  Management of recurrent priapism with epinephrine self-injection and gonadotropin-releasing hormone analogue.

Authors:  J Steinberg; R C Eyre
Journal:  J Urol       Date:  1995-01       Impact factor: 7.450

6.  Alpha thalassemia and stroke risk in sickle cell anemia.

Authors:  R J Adams; A Kutlar; V McKie; E Carl; F T Nichols; J C Liu; K McKie; A Clary
Journal:  Am J Hematol       Date:  1994-04       Impact factor: 10.047

7.  Mortality in sickle cell disease. Life expectancy and risk factors for early death.

Authors:  O S Platt; D J Brambilla; W F Rosse; P F Milner; O Castro; M H Steinberg; P P Klug
Journal:  N Engl J Med       Date:  1994-06-09       Impact factor: 91.245

8.  Sickle cell disease as a cause of osteonecrosis of the femoral head.

Authors:  P F Milner; A P Kraus; J I Sebes; L A Sleeper; K A Dukes; S H Embury; R Bellevue; M Koshy; J W Moohr; J Smith
Journal:  N Engl J Med       Date:  1991-11-21       Impact factor: 91.245

9.  Follow-up of sickle cell disease patients with priapism treated by hydroxyurea.

Authors:  Sara T O Saad; Camila Lajolo; Simone Gilli; José Francisco C Marques Júnior; Carmen S Lima; Fernando F Costa; Valder R Arruda
Journal:  Am J Hematol       Date:  2004-09       Impact factor: 10.047

10.  The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease.

Authors:  O Castro; D J Brambilla; B Thorington; C A Reindorf; R B Scott; P Gillette; J C Vera; P S Levy
Journal:  Blood       Date:  1994-07-15       Impact factor: 22.113

View more
  70 in total

1.  Laboratory and echocardiography markers in sickle cell patients with leg ulcers.

Authors:  Caterina P Minniti; James G Taylor; Mariana Hildesheim; Patricia O'Neal; Jonathan Wilson; Oswaldo Castro; Victor R Gordeuk; Gregory J Kato
Journal:  Am J Hematol       Date:  2011-05-31       Impact factor: 10.047

2.  Pulmonary hypertension and NO in sickle cell.

Authors:  Mark T Gladwin; Robyn J Barst; Oswaldo L Castro; Victor R Gordeuk; Cheryl A Hillery; Gregory J Kato; Daniel B Kim-Shapiro; Roberto Machado; Claudia R Morris; Martin H Steinberg; Elliott P Vichinsky
Journal:  Blood       Date:  2010-08-05       Impact factor: 22.113

Review 3.  Genetic modifiers of sickle cell disease.

Authors:  Martin H Steinberg; Paola Sebastiani
Journal:  Am J Hematol       Date:  2012-05-28       Impact factor: 10.047

4.  Cerebrovascular disease associated with sickle cell pulmonary hypertension.

Authors:  Gregory J Kato; Matthew Hsieh; Roberto Machado; James Taylor; Jane Little; John A Butman; Tanya Lehky; John Tisdale; Mark T Gladwin
Journal:  Am J Hematol       Date:  2006-07       Impact factor: 10.047

5.  Storage lesion: role of red blood cell breakdown.

Authors:  Daniel B Kim-Shapiro; Janet Lee; Mark T Gladwin
Journal:  Transfusion       Date:  2011-04       Impact factor: 3.157

Review 6.  Sickle cell disease and nitric oxide: a paradigm shift?

Authors:  A Kyle Mack; Gregory J Kato
Journal:  Int J Biochem Cell Biol       Date:  2006-02-17       Impact factor: 5.085

7.  Hemolysis-associated hypercoagulability in sickle cell disease: the plot (and blood) thickens!

Authors:  Mark T Gladwin; Gregory J Kato
Journal:  Haematologica       Date:  2008-01       Impact factor: 9.941

Review 8.  Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics.

Authors:  Zahra Pakbaz; Ted Wun
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

Review 9.  Pleiotropic effects of intravascular haemolysis on vascular homeostasis.

Authors:  Gregory J Kato; James G Taylor
Journal:  Br J Haematol       Date:  2009-12-01       Impact factor: 6.998

10.  Priapism in patients with hemolytic disorders: a nationwide retrospective cohort study.

Authors:  Stinne Tranekær; Dennis Lund Hansen; Bart J Biemond; Anne Lykke Sørensen; Andreas Glenthøj; Jesper Petersen; Henrik Frederiksen
Journal:  Ann Hematol       Date:  2021-06-16       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.